{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-073209","form_type":"8-K","ticker":"SLNO","cik":"0001484565","company_name":"SOLENO THERAPEUTICS INC","filed_at":"2026-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.177653+00:00","generated_at":"2026-05-15T23:32:14.435470+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Soleno Therapeutics appoints Jennifer Fulk as CFO, succeeding retiring James Mackaness","bullets":["Jennifer Fulk appointed CFO effective March 2, 2026; base salary $525k, target bonus 45%, option for 67,660 shares, RSUs for 39,200 shares.","James Mackaness retiring by end of March 2026, will consult through December 2026 for smooth transition.","Fulk brings 20+ years experience including 15 years at Eli Lilly, most recently CFO/COO at 120Water and CFO at Talkspace.","Fulk will participate in Soleno's Key Executive Change in Control and Severance Plan."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-073209","json":"https://secwatch.observer/filing/0001193125-26-073209.json","markdown":"https://secwatch.observer/filing/0001193125-26-073209.md","text":"https://secwatch.observer/filing/0001193125-26-073209.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1484565/000119312526073209/0001193125-26-073209-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1484565/000119312526073209/d110816d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T23:32:14.435470+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}